Status:

COMPLETED

HPA Antibodies and the Distribution of Antigen and Antibodies

Lead Sponsor:

Guangzhou First People's Hospital

Collaborating Sponsors:

LanZhou University

First Affiliated Hospital of Harbin Medical University

Conditions:

Blood Disease

Platelet Refractoriness

Eligibility:

All Genders

Phase:

NA

Brief Summary

By detecting platelet antibodies of participants and then further to identify their genotype and analyzing laboratory examination, the investigators will obtain positive frequency of HPA antibodies, t...

Detailed Description

1. The investigators will detect platelet antibodies of participants who are according with the inclusive criteria. 2. For participants with platelet antibodies, the investigators should screen out ca...

Eligibility Criteria

Inclusion

  • Blood disease patients with voluntary participation in creating records, no gender limitation, 0-99 years of age, first diagnosed or be hospitalized in our hospital with platelet transfusion more than once.
  • Patients transfers from other hospitals which can be confirm the time (\>1) of platelet transfusion.
  • Patient be cured, discharged or dead with the time of platelet transfusion is between 1 to 10 should be included.
  • Patient with HPA antibodies at admission could be considered to be included into same type transfusion group.
  • \-

Exclusion

  • Patients informed but refuse to participate in;
  • Patients with HPA antibodies quitting therapy or breaking off cooperation during research;
  • Patients with many referrals and the time of platelet transfusion can not be confirmed;
  • Patient without platelet transfusion;
  • Patient with termination of treatment whatever active or passive. -

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2020

Estimated Enrollment :

6170 Patients enrolled

Trial Details

Trial ID

NCT03408158

Start Date

January 1 2017

End Date

December 31 2020

Last Update

August 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Guangzhou First People's Hospital

Guangzhou, Guangdong, China, 210000